COMPARING CHROMOENDOSCOPY AND WHITE LIGHT VIDEO ENDOSCOPY FOR ESOPHAGEAL DYSPLASIA AND CANCER SURVEILLANCE IN PATIENTS WITH ACHALASIA

COMPARING CHROMOENDOSCOPY AND WHITE LIGHT VIDEO ENDOSCOPY FOR ESOPHAGEAL DYSPLASIA AND CANCER SURVEILLANCE IN PATIENTS WITH ACHALASIA - none

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON30825

Enrollment

Registered

2007-03-21

Start date

2008-01-07

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal motility disorder movement disorder of the esophagus

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: A) Age 18 years or older B) Patients with primary achalasia as diagnosed according to standard criteria

Exclusion criteria

Exclusion criteria: A) Under 18 years of age B) Known allergy against iodine C) Hyperthyroidism D) Esophageal varices E) Barrett*s esophagus F) Heart failure (New York Heart association III-IV) G) Coagulopathy (prothrombin time 50 seconds) or anticoagulant use that can not be discontinued

Design outcomes

Primary

Measure	Time frame
Primary end point is the difference between WLE and CE for detection of dysplastic lesions or oesophageal carcinoma during gastroscopy in patients with achalasia.	—

Secondary

Measure	Time frame
- Histological difference of the lesions detected only by WLE or only by CE - Duration of the procedure for WLE and CE	—

Countries

Netherlands

Outcome results